Original studyAntihypertensive efficacy of a once a day verapamil SR/ trandolapril combination☆
References (18)
- et al.
Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris
Am J Cardiol
(1982) - et al.
Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570)
Eur J Pharmacol
(1988) - et al.
Cardiac effect of trandolapril in hypertension
Am Heart J
(1993) - et al.
Clinical experiences with trandolapril
Am Heart J
(1993) - et al.
The treatment of hypertension with verapamil
Aus NZ J Med
(1978) - et al.
Treatment of hypertension with verapamil
Curr Ther Res
(1979) - et al.
Hypertensive and renal effects of orally administered verapamil
Eur J Clin Pharmacol
(1980) - et al.
Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension
J Cardiovasc Pharmacol
(1982) - et al.
The role of a slow channel inhibitor, verapamil, in the management of hypertension
Clin Exp Pharmacol Physiol
(1982)
There are more references available in the full text version of this article.
Cited by (8)
Trandolapril: A newer angiotensin-converting enzyme inhibitor
2003, Clinical TherapeuticsEffects of verapamil slow release plus trandolapril combination therapy on essential hypertension
2003, Current Therapeutic Research - Clinical and ExperimentalPharmacoeconomics of combination antihypertensive therapy
2001, Blood Pressure MonitoringThe fixed combination of verapamil SR/trandolapril
2000, Expert Opinion on PharmacotherapyCost effectiveness of combination therapy
1999, American Journal of Managed Care
- ☆
The study was supported by a grant from Knoll AG, Ludwigshafen, Germany.
Copyright © 1996 Published by Elsevier Ireland Ltd.